| 2024/09/26 19:31:42 | |
|---|---|
| Price | |
| 211.50 EUR | |
| Difference | 0.33% (0.70) |
General attributes
| ISIN | US0758871091 |
| Symbol | BDX |
| Exchange | Duesseldorf |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 61,365 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 210.90 EUR |
| High | 211.50 EUR |
| Low | 210.50 EUR |
| Close (prev. day) | 210.80 EUR |
| VWAP | 187.53 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 7 |
| Last size | 0 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BECTON DICKINSON AND CO. |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2024/09/11 |
|
Global Equity Ratings |
|
| 2024/09/05 |
|
Global Equity Ratings |
|
| 2024/08/12 |
|
Global Equity Ratings |
|
| 2024/07/24 |
|
Global Equity Ratings |
|
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/09/26 19:31:42 | |
|---|---|
| Price | |
| 211.50 EUR | |
| Difference | 0.33% (0.70) |
General attributes
| ISIN | US0758871091 |
| Symbol | BDX |
| Exchange | Duesseldorf |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 61,365 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 210.90 EUR |
| High | 211.50 EUR |
| Low | 210.50 EUR |
| Close (prev. day) | 210.80 EUR |
| VWAP | 187.53 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 7 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -4.73% | -14.55% | +0.24% |
| Perf (abs.) | -10.50 | -36.00 | +0.50 |
| Beta | 0.31 | 0.40 | 0.48 |
| Volatility | 17.85 | 19.08 | 20.08 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 210.54 EUR (0) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 212.27 EUR (0) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 214.23 EUR (1) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 219.48 EUR (0) |
| YTD High | date | 228.50 EUR (2024/03/28) |
| YTD Low | date | 203.50 EUR (2024/07/10) |
| 52 Weeks High | date | 252.50 EUR (2023/10/10) |
| 52 Weeks Low | date | 203.50 EUR (2024/07/10) |
All listings for BECTON DICKINSON AND CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/09/26 | 17:35 | 211.40 EUR | 0.01 | 5 |
| Vienna Stock Exchange | 2024/09/26 | 17:32 | 211.20 EUR | 0.00 | 5 |
| Tradegate | 2024/09/26 | 22:26 | 212.30 EUR | 0.11 | 19 |
| Stuttgart | 2024/09/26 | 21:31 | 210.90 EUR | 0.00 | 5 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 243.39 CHF | 0.00 | 1 |
| NYSE | 2024/09/26 | 22:00 | 237.27 USD | 246.40 | 20,814 |
| Munich | 2024/09/26 | 08:00 | 211.00 EUR | 0.00 | 2 |
| London Stock Exchange | 2024/09/26 | 16:01 | 234.9020 USD | 0.11 | 3 |
| Frankfurt | 2024/09/26 | 15:34 | 209.50 EUR | 0.01 | 2 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0.00 | - |
| Euronext Milan MTF Global Equity Market | 2024/09/26 | 17:44 | 211.10 EUR | 0.00 | 1 |
| Duesseldorf | 2024/09/26 | 19:31 | 211.50 EUR | 0.00 | 7 |
| Berlin | 2024/09/26 | 08:08 | 211.10 EUR | 0.00 | 3 |
Company Logo
Contact Details
| BECTON DICKINSON & CO. |
| - - |
| 1 Becton Drive - 07417-1880 Franklin Lakes |
| Telefon: +1-201-847-6800 |
| Fax: + |
| E-mail: customer_support@bd.com |
PDF Downloads
| Company report: BECTON DICKINSON AND CO. | |
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ. |
Members of Management Board
| Carrie Byington | Member of Board of Directors |
| Claire Fraser-Liggett | Member of Board of Directors |
| Joanne Waldstreicher | Member of Board of Directors |
| Bertram Scott | Member of Board of Directors |
| Catherine Burzik | Member of Board of Directors |
| Christopher Jones | Member of Board of Directors |
| Jeffrey Henderson | Member of Board of Directors |
| Robert Eckert | Member of Board of Directors |
| Timothy Ring | Member of Board of Directors |
| William Brown | Member of Board of Directors |
| Thomas E. Polen | Chairman of Managing Board |
| Ami Simunovich | Member of Executive Committee |
| Christopher DelOrefice | Member of Executive Committee |
| Dave Hickey | Member of Executive Committee |
| David Shan | Member of Executive Committee |
| Denise Fleming | Member of Executive Committee |
| Elizabeth McCombs | Member of Executive Committee |
| Jeff Silvestri | Member of Executive Committee |
| Michael Garrison | Member of Executive Committee |
| Michelle Quinn | Member of Executive Committee |
| Pavan Mocherla | Member of Executive Committee |
| Richard Byrd | Member of Executive Committee |
| Roland Goette | Member of Executive Committee |
| Shana Neal | Member of Executive Committee |
| Tony Ezell | Member of Executive Committee |